You are here

Article Text

Article menu
Download PDFPDF
Cognition
Review
HIV, dementia and antiretroviral drugs: 30 years of an epidemic
  1. Hadi Manji1,
  2. H R Jäger2,3,
  3. Alan Winston4,5
  1. 1MRC Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, USA
  2. 2Lysholm Department of Neuroradiology, The National Hospital for Neurology and Neurosurgery, London, USA
  3. 3Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, London, UK
  4. 4Department of Medicine, Faculty of Medicine, Imperial College London, London, UK
  5. 5Department of HIV and GU Medicine, Imperial College Healthcare NHS Trust, London, UK
  1. Correspondence to Dr Hadi Manji, MRC Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK; hadi.Manji{at}uclh.nhs.uk

Abstract

Neurological complications due to the HIV itself became apparent early on in the course of the AIDS epidemic. The most feared were the cognitive and motor complications termed AIDS dementia complex or HIV-associated dementia. With the introduction of combination antiretroviral therapy, the incidence of HIV-associated dementia has been dramatically reduced. However, the prevalence of less severe forms of the disorder remains around 20%. There is controversy about whether some patients may continue with progressive cognitive decline despite adequate suppression of the HIV. The salient issues are those of cerebrospinal fluid (CSF) drug penetration, drug neurotoxicity and persistent immune activation and inflammation. This review will also discuss other newly encountered complications, including the compartmentalisation (or CSF escape) and immune reconstitution inflammatory syndromes.

  • AIDS
  • Dementia
  • Neuropathology
  • MRI
  • CSF

https://doi.org/10.1136/jnnp-2012-304022

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text